SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...

MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

A team at RMIT University in Melbourne say that extremely small metal particles – which they dub ‘nanodots’ – could be ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

The one-and-a-half-day symposium will provide an overview of recent advances in the treatment of solid tumors with novel ...

Researchers have identified a single protein whose absence can cripple tumors in mice, slowing their growth and in some cases ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...